We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
-3.9%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$41B
AUM Growth
-$154M
(-0.37%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
3.77%
Top 10 Holdings %
Top 10 Hldgs %
24.64%
Holding
1,487
New
71
Increased
739
Reduced
386
Closed
163
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Deutsche Bank
DB
|
+$283M |
| 2 |
Sysco
SYY
|
+$90.6M |
| 3 |
Microsoft
MSFT
|
+$90M |
| 4 |
NVIDIA
NVDA
|
+$78.2M |
| 5 |
Carlyle Group
CG
|
+$75.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$112M |
| 2 |
Brookfield
BN
|
+$91.7M |
| 3 |
NXP Semiconductors
NXPI
|
+$76.9M |
| 4 |
Suncor Energy
SU
|
+$69.5M |
| 5 |
Mercado Libre
MELI
|
+$63.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.74% |
| 2 | Healthcare | 17.3% |
| 3 | Financials | 11.28% |
| 4 | Consumer Discretionary | 9.64% |
| 5 | Industrials | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
California Resources
CRC
$4.81B
| $530K | ﹤0.01% |
11,194
-1,750
| -14% | -$75.4K |
|
1052
Ligand Pharmaceuticals
LGND
$5.76B
| $527K | ﹤0.01% |
7,278
+642
| +10% | +$46.6K |
|
1053
International Money Express
IMXI
$351M
| $521K | ﹤0.01% |
+24,591
| New | +$423K |
|
|
SRCL
1054
DELISTED
Stericycle Inc
SRCL
| $517K | ﹤0.01% |
8,700
| – | – |
|
|
RETA
1055
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $514K | ﹤0.01% |
16,640
+1,500
| +10% | +$44.5K |
|
1056
Prothena Corp
PRTA
$473M
| $511K | ﹤0.01% |
14,000
+1,300
| +10% | +$46.9K |
|
1057
Reinsurance Group of America
RGA
$16B
| $507K | ﹤0.01% |
4,600
+4,516
| +5,376% | +$500K |
|
|
RVNC
1058
DELISTED
Revance Therapeutics, Inc.
RVNC
| $507K | ﹤0.01% |
26,100
-2,100
| -7% | -$31.8K |
|
|
ROIC
1059
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $493K | ﹤0.01% |
25,246
+35
| +0.1% | +$653 |
|
|
NSTG
1060
DELISTED
NanoString Technologies, Inc.
NSTG
| $490K | ﹤0.01% |
14,350
+1,300
| +10% | +$44.8K |
|
1061
Syndax Pharmaceuticals
SNDX
$1.81B
| $488K | ﹤0.01% |
28,300
+2,600
| +10% | +$43.8K |
|
1062
RLJ Lodging Trust
RLJ
$1.65B
| $487K | ﹤0.01% |
34,209
-106
| -0.3% | -$1.49K |
|
1063
Sony
SONY
$138B
| $486K | ﹤0.01% |
23,200
-6,955
| -23% | -$151K |
|
1064
Allogene Therapeutics
ALLO
$732M
| $485K | ﹤0.01% |
51,900
+700
| +1% | +$7.29K |
|
1065
Fastly Inc
FSLY
$4.58B
| $482K | ﹤0.01% |
+27,000
| New | +$630K |
|
1066
Hawaiian Electric Industries
HE
$2.05B
| $482K | ﹤0.01% |
11,230
| – | – |
|
1067
Seres Therapeutics
MCRB
$46.6M
| $482K | ﹤0.01% |
3,350
| – | – |
|
1068
C4 Therapeutics
CCCC
$476M
| $477K | ﹤0.01% |
19,800
+1,800
| +10% | +$43.7K |
|
|
SGI
1069
Somnigroup International
SGI
$13.7B
| $477K | ﹤0.01% |
16,450
+201
| +1% | +$7.41K |
|
1070
RLX Technology
RLX
$2.42B
| $470K | ﹤0.01% |
30,066
-5,666
| -16% | -$16.9K |
|
|
TPTX
1071
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $468K | ﹤0.01% |
17,350
+480
| +3% | +$16.1K |
|
1072
Schrodinger
SDGR
$1.4B
| $467K | ﹤0.01% |
13,600
+7,500
| +123% | +$228K |
|
1073
CACI
CACI
$14.8B
| $465K | ﹤0.01% |
1,528
-703
| -32% | -$194K |
|
1074
Urban Edge Properties
UE
$2.73B
| $459K | ﹤0.01% |
23,702
+170
| +0.7% | +$3.15K |
|
|
XHR
1075
Xenia Hotels & Resorts
XHR
$1.72B
| $457K | ﹤0.01% |
23,430
+80
| +0.3% | +$1.46K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q1 2022 Portfolio in Review
As of Q1 2022, DekaBank Deutsche Girozentrale held 1,487 positions worth $41B, down 0.37% from $41.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
DekaBank Deutsche Girozentrale deployed $1.55B of net new capital in Q1 2022, opening 71 new positions and adding to 739 existing holdings. Its largest new stake was Deutsche Bank: 21,257,223 shares worth $279M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Brookfield, an estimated $91.7M trimmed.
- DekaBank Deutsche Girozentrale's largest Q1 2022 buy was Deutsche Bank: 21,257,223 shares worth $279M.
- DekaBank Deutsche Girozentrale added most to Sysco in Q1 2022, an estimated $90.6M increase.
- DekaBank Deutsche Girozentrale's biggest Q1 2022 reduction was Brookfield, cutting an estimated $91.7M.
- DekaBank Deutsche Girozentrale fully exited Marvell Technology in Q1 2022, selling an estimated $112M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 25% of its $41B portfolio in Q1 2022.
- DekaBank Deutsche Girozentrale opened 71 new positions and closed 163 in Q1 2022.
- DekaBank Deutsche Girozentrale's portfolio value fell 0.37% quarter-over-quarter to $41B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2022, filed 28 Apr 2022.